Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685516 · ClinicalTrials.gov registry record · NA
Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT00685516 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 113 participants.
The verdict
NCT00685516, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
RATIONALE: Green tea contains ingredients that may prevent or slow the growth of certain cancers. It is not yet known whether green tea is more effective than black tea or water in treating prostate cancer. PURPOSE: This randomized phase II trial is studying green tea to see how well it works compared with black tea and water in treating patients with prostate cancer undergoing surgery.
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT green tea
- DIETARY_SUPPLEMENT decaffeinated black tea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2007-09-01 |
| Est. Completion | 2015-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685516
The ClinicalTrials.gov registry entry for NCT00685516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00685516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00685516 about?
NCT00685516 is a clinical study titled "Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery". RATIONALE: Green tea contains ingredients that may prevent or slow the growth of certain cancers. It is not yet known whether green tea is more effective than black tea or water in treating prostate cancer. PURPOSE: This randomized phase II trial is studying green tea to see how well it works compa...
What is the current status of trial NCT00685516?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2007-09-01. Estimated completion is 2015-04-01.
What interventions are being tested in trial NCT00685516?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), green tea (DIETARY_SUPPLEMENT), decaffeinated black tea (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00685516?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.